COMPANY Data
Movers and SHAKERS

Ticker | MTNB (AMERA) |
Current Price | $1.64 ↓ -0.03 |
Market Cap | 327.41M |
Volume | 3.54M |
52wk Range | $0.50 - $2.23 |
ADVANCED MARKET DATA |

Advanced Market Data
Matinas Biopharma Holdings Inc. (MTNB)Overview
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. Its lead anti-fungal product candidate, MAT2203, safely and effectively delivers anti-infective therapies utilizing its proprietary LNC formulation technology. In addition, it is pursuing the development of MAT9001 which is a prescription-only omega-3 fatty acid-based composition, comprised primarily of EPA and DPA, under development for hypertriglyceridemia, which has shown superiority versus Vascepa (icosapent ethyl) in reducing serum triglycerides, Total- and Non-HDL-Cholesterol, apolipoproteins, and PCSK9 levels.
MTNB 1582554 MATINAS BIOPHARMA HOLDINGS, INC. 1582554 MATINAS BIOPHARMA HOLDINGS, INC. MTNB 0001493152-21-000992 8-K Current report pursuant to Section 13 or 15(d) 8k 20210114 20210114 https://qm.kscope.io/outline?docid=115551064&CK=1582554 https://qm.kscope.io/downloadDoc?docid=115551064&CK=1582554&format=word https://qm.kscope.io/downloadDoc?docid=115551064&CK=1582554&format=pdf https://qm.kscope.io/downloadDoc?docid=115551064&CK=1582554&format=xls https://qm.kscope.io/outline?docid=115551064&isxbrl=1 https://qm.kscope.io/outline?docid=115551064&isixbrl=1 115551064
Matinas Biopharma Holdings Inc. Corporate Filings
Matinas Biopharma Holdings Inc. Corporate Events
Matinas Biopharma Holdings Inc. Press Releases / News Feed
Channelchek
Not available
Channelchek
No reports available